The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly presented awards to seven outstanding volunteer leaders whose impact has pushed ...

Two top clinicians have been disciplined amid growing concern that Kaiser’s system for monitoring research safety and ethics is inadequate.

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new small molecule therapeutic a ...

If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...

Satellos Announces Completed Enrollment of all Four Multiple-Ascending Dose Cohorts for the Phase 1 Clinical Trial of SAT-3247 in Healthy Volunteers ... its breakthrough research and proprietary ...

With Purdue sports and nearby Indianapolis as a sports hub, a new master's program Purdue's trustees recently OK'd seeks to ...

THB335 Phase 1 data support advancement into Phase 2 clinical trial in chronic spontaneous urticaria (CSU)Company initiating process to leverage ...

Announced that topline data from the monotherapy Phase 3 VERITAC-2 trial isanticipated in 1Q25 –– Presented Phase 1b data from the TACTIVE-U ...

Along with claiming the lives of 1.2 million Americans, the COVID-19 pandemic has been described as a mass disabling event. Estimates vary, but the CDC puts it at 17 million adults.

Eleven scientists will be recognized for their individual exceptional professional achievements and contributions to stroke care and research during the American Stroke Association’s International ...